Activities of daily living – outcome during two years in galantamine treated Alzheimer patients

After two years of galantamine treatment the total mean change from baseline in IADL-score was 4,3 ± 4,9 (mean ± SD) points. Using the mathematical model by Green et al.[1] patients in this study are expected to decline approximately 11,7 ± 3,3 points on IADL score after 2 years. The IADL changes from baseline show a strong linear relationship (0,000

Keywords:

• Internal medicine
• Activities of daily living
• Galantamine

• Correction
• Cite
• Save
• Machine Reading By IdeaReader